BioSpace News Archive

The screening and workforce reentry solution includes clinically overseen COVID-19 diagnostic and antibody testing; a population analytics, engagement, and monitoring technology platform; and a comprehensive return-to-work action plan. [05-June-2020] ATLANTA , June 5, 2020 /PRNewswire/ -- BioIQ , a healthcare engagement and clinical adherence technology platform comp

UroGen Pharma Ltd. a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options, announced the grants of inducement restricted stock units on June 3, 2020 to eight new employees in connection with their employment with UroGen.

Cibus, a pioneer in precision gene editing in agriculture, will advance herbicide tolerance traits in rice and flax crops to commercial development following United States Department of Agriculture’s Animal and Plant Health Inspection Service (USDA-APHIS) Biotechnology Regulatory Services (BRS) confirm

Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today announced the following publications in peer-reviewed journals. The publication titled “Intravenous Tramadol is Effective in the Management of Postoperative Pain Following Abdominoplasty: A Three-Arm Randomized Placebo- and Active-Controlled Trial” has been published in Drugs in R&D and can be acc

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced the pricing of its initial public offering of 18,425,000 American depositary shares (ADSs), each representing two ordinary shares, at a public offering price of $23.00 per ADS, for total gross procee

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will participate in the upcoming 41 st Annual Goldman Sachs Global Healthcare Conference on Thursday, June 11, 2020 . Charles M. Baum , M.D., Ph.D., President and Chief Executive Officer at Mirati will represent the Company during the fireside

Check-Cap Ltd . (the “Company” or “Check-Cap”) (NASDAQ: CHEK), a clinical-stage medical diagnostics company advancing the development of C-Scan ® , the first and only preparation-free ingestible capsule for the prevention of colorectal cancer through the detection of precancerous polyps, today announced that the Company received a let

BioMarker Strategies, LLC, a company focused on helping make precision medicine more of a reality for patients with solid tumor cancers, today announced that President and CEO Jerry Parrott will present at BIO Digital. BIO Digital replaces BIO 2020, the Biotechnology Innovation Organization’s International Convention, which was originally scheduled

AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on June 1, 2020 AgeX received a Deficiency Letter from the staff of the NYSE American (the “Exchange”) indicating that AgeX does not meet certain of the Exchange’s continued listing standards as set forth in Section 1003(a)(i) of the Exchange Company Guide in that Age

The global tinnitus market exhibited impressive growth in the recent past as the number of people suffering from tinnitus has been increasingly continuously.